Nanopharm-logo-with-signature-Pantone (1)
Close this search box.

White Papers

Nanopharm White Papers

Gain comprehensive insights into OINDP devices, formulations, and development strategies by exploring our collection of white papers. These in-depth documents offer detailed discussions on various nasal and inhaled drug product subjects, such as the space’s unique regulatory requirements, device design features, human use studies, and complex formulation optimization. Nanopharm’s white papers provide a deep dive into complex OINDP topics, elucidating key challenges and proposing innovative solutions. Whether you are an industry professional, regulatory authority, or academic researcher, our white papers can serve as a valuable resource to enhance your understanding of nasal and inhaled drug device combination products.

6 February 2024

Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2

Nasal, Nasal Sprays, Respiratory, SARS-CoV-2